ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION 
N83-080,Duloxetine,"CYP1A2CYP2D6","Minor – result should be considered as may affect medicationresponse","INHIBITOR MODERATE: CYP2D6, INCREASED RISK OF SEROTONIN TOXICITY WITH DEXTROAMPHETAMINE AND AMPHETAMINE"
N83-080,Esomeprazole,CYP2C19,"Minor – result should be considered as may affect medicationresponse",INHIBITOR MODERATE: CYP2C19
N83-080,Propranolol,"CYP1A2CYP2D6","Minor – result should be considered as may affect medicationresponse",NA
N83-080,Codeine,"CYP2D6OPRM1",Usual prescribing considerations apply,NA
N83-080,Dextroamphetamine (component of Apo-Amphetamine Xr),CYP2D6,Usual prescribing considerations apply,INCREASED RISK OF SEROTONIN TOXICITY WITH DULOXETINE AND AMPHETAMINE
N83-080,domperidone,NA,NO,NA
N83-080, tamsulosin,NA,NO,NA
N83-080, trazadone,NA,NO,NA
N83-080, amphetamine (component of Apo-Amphetamine Xr),NA,NO,INCREASED RISK OF SEROTONIN TOXICITY WITH DULOXETINE AND DEXTROAMPHETAMINE
